TrialNeuro-oncology2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
Kathryn M Field et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this paperpooled ittrialcites it